China Medical Group (08225) launches a series of AI-RWS research projects to lead the new track of "AI + clinical research".

Wisdom Financial News App reported that China Medical Group (08225) announced that they recently successfully held the "AI-RWS Real World Research Summit" in Shanghai, and launched more than ten AI-driven real-world research (AI-RWS) projects focusing on two common mental neurological illnesses in China: adolescent mental disorders and behavioral and psychological symptoms of dementia (BPSD) in the elderly. This move signifies a key step in the company's strategic layout in the Hong Kong stock market's "AI+ clinical research" track, further solidifying its leading position in the industry.